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Abstract: 
Novel compounds with significant medicinal properties have gained much interest in therapeutic approaches for treating various 
inflammatory disorders like arthritis, odema and snake bites and the post-envenom (impregnating with venom) consequences. 
Inflammation is caused by the increased concentration of secretory Phospholipases A2 (sPLA2s) at the site of envenom. A novel 
compound Tris(2,4-di-tert-butylphenyl) phosphate (TDTBPP) was isolated from the leaves of Vitex negundo and the crystal 
structure was reported recently. The acute anti-inflammatory activity of TDTBPP was assessed by Carrageenan-induced rat paw 
odema method. TDTBPP reduced the raw paw odema volume significantly at the tested doses of 50 mg/kg and 70 mg/kg body 
weight. Molecular docking studies were carried out with the X-ray crystal structures of Daboia russelli pulchella’s (Vipera russelli, 
Indian Russell’s viper) venom sPLA2 and Human non-pancreatic secretory PLA2 (Hnps PLA2) as targets to illustrate the anti-
inflammatory and antidote activities of TDTBPP. Docking results showed hydrogen bond (H-bond) interaction with Lys69 residue 
lying in the anti-coagulant loop of D. russelli’s venom PLA2, which is essential in the catalytic activity of the enzyme and 
hydrophobic interactions with the residues at the binding site (His48, Asp49). Docking of TDTBPP with Hnps PLA2 structure 
showed coordination with calcium ion directly as well as through the catalytically important water molecule (HOH1260) located at 
the binding site.  
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Background:  
The importance of natural products in modern medicine has 
been well recognized. Natural compounds isolated from plant 
sources have an extensive past and present use in the treatment 
of diverse diseases. They also serve as compounds of interest 
both in their natural form and also templates for synthesizing 
derivatives with higher activity and lower toxicity. More than 
20 new drugs, launched worldwide between 2000 and 2005, 
originate from natural products. Scrutiny of medical indications 
by source of compounds has demonstrated that natural 
products and related drugs are used to treat 87% of all 
categorized infectious and non-infectious human diseases [1]. 
Vitex negundo (verbenaceae) is an important Indian medicinal 
p l a n t ,  w h i c h  i s  a  s o u r c e  o f  s u c h  n a t u r a l  c o m p o u n d s .  I t  i s  a  BIOINFORMATION  open access 
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medicinal herb and various parts of the plant have been 
employed in the folklore systems of medicine in Asia including 
India, China and Malaysia for various diseases. Many 
ethnobotanical and pharmacological activities of V. negundo 
have been reported such as: analgesic and anti-inflammatory 
activity  [2, 3], antioxidant activity [4], enzyme inhibitions [5], 
nitric oxide scavenging activity [6], antiradical and 
antilipoperoxidative activity [7], CNS activity [8], 
hepatoprotective activity [9], anti-bacterial activity [10], anti-
fungal activity [11], larvicidal activity [12], antiandrogenic 
effects  [13]  and mosquito repellent activity [14].  V. negundo 
leaves were found to have NSAIDs like activity and fresh leaves 
have been suggested to possess anti-inflammatory and pain 
suppressing activities possibly mediated via prostaglandin (PG) 
synthesis inhibition [15]. The leaf extract was also used as 
adjuvant to standard anti-inflammatory drug [16]. The 
methanolic extract of roots was reported to have snake venom 
neutralizing property [17]. Many biologically active compounds 
have been isolated from this plant in the past. Recently we 
isolated and purified a Polyphenyl compound TDTBPP from 
the ethyl acetate extract of V. negundo leaves and reported its 
crystal structure (Figure 1) [18]. Phospholipases A2 (PLA2s; EC 
3.1.1.4) are enzymes that play a major role in the formation of 
pro-inflammatory and inflammatory mediators such as 
prostaglandins, leukotrienes, platelet-aggregating factor and 
lysophospholipids  [19, 20]. These enzymes catalyse the 
hydrolysis of sn-2 acyl bond of phospholipids to produce 
unsaturated fatty acids and lysophospholipids. Arachidonic 
acid, one of the fatty acids released by the hydrolysis can lead to 
the biosynthesis of eicosanoids and hydrolysis of cellular 
phospholipids of the activated inflammatory cells and therefore 
acts as a very important inflammatory precursor. Increased 
concentrations of eicosanoids are found in the state of 
inflammation  [21]. PLA2s are classified as intracellular and 
extracellular. Intracellular PLA2s are of high molecular weight 
and involved in phospholipid metabolism, signal transduction 
and other cellular processes [22]. Extracellular PLA2/secretory 
PLA2 (sPLA2) are of low molecular weight and found in 
mammalian pancreatic juice, snake and insect venoms [23-25]. 
The release of arachidonic acid by sPLA2 is followed by the 
eicosanoid production. Hence, sPLA2s are considered as “the 
inflammatory PLA2s” and act as target for anti-inflammatory 
drugs. Thus, inhibition of PLA2 by various biologically active 
substances has gained therapeutic importance. Most of the 
natural compounds and their derivatives interfere directly or 
indirectly with specific molecules or mechanisms, such as 
various inflammatory mediators (arachidonic acid metabolites, 
peptides, cytokines etc.), production or action of second 
messengers (cGMP, cAMP, various protein kinases) and in 
release of pro-inflammatory molecules [26]. The present study 
was undertaken to illustrate the anti-inflammatory activity of 
TDTBPP by carrageenan-induced rat paw odema model and to 
carry out Molecular docking studies (in silico) carried out with 
the X-ray crystal structures of PLA2-inhibitor complexes 
available in the Protein Data Bank (PDB; http://www.pdb.org/pdb) 
to illustrate the interactions exhibited by TDTBPP with the 
target protein. D. russelli venom sPLA2 (PDB ID: 3H1X) [27] and 
Hnps PLA2 (PDB ID: 1KVO) [28] structures were chosen for 
docking studies. The favorable interactions of TDTBPP with the 
active site residues of the sPLA2 could be correlated with the 
potency and the compound is proved to be an anti-
inflammatory agent as well as an antidote. TDTBPP therefore 
could be co-crystallized with sPLA2 and the in  vitro binding 
mode can be studied. 
 
 
Figure 1: Crystal structure of TDTBPP (displacement ellipsoids 
drawn at 30% probability level. Hydrogen atoms are omitted 
for clarity 
 
Methodology: 
Animal Model Studies: 
Chemicals & drugs: 
The Carrageenan and Sodium carboxymethyl cellulose were 
purchased from Himedia Laboratories, Mumbai and the 
standard Non-Steroid Anti-Inflammatory Drug (NSAID) 
Indomethacin was purchased from Sigma Aldrich, Germany. 
 
Animals: 
The experiments were carried out in the animal house of Center 
of Advanced Study in Marine Biology, Annamalai University, 
Chidambaram. Albino rats of Wistar strains of either sex 
weighing between 120-150 g were chosen for study. The 
animals were kept on diet and allowed food and water ad 
libitum. They were housed in polypropylene cages maintained 
under standard conditions.  
 
Preparation of Sample: 
TDTBPP was separated and purified as mentioned in our 
previous studies [18]. The crystals of TDTBPP obtained from the 
ethyl acetate extract of V. negundo L. were crushed in to fine 
powder, lyophilized and suspended in 0.1% sodium 
carboxymethyl cellulose in 1M phosphate buffer pH 7.2 
(vehicle) and used for the study. It is one of the most commonly 
used vehicles and has no effect on the activity. 
 
Evaluation of anti-inflammatory activity: 
Acute anti-inflammatory activity was evaluated by 
carrageenan-induced rat paw odema method. The ethical 
clearance was obtained by the Institutional Animal Ethics 
(Registration No: 4620/1A/2011/CPCSEA) before carrying out 
the experiment. 
 
Statistical Analysis: 
The experimental data were expressed as the mean + standard 
error (SE). The standard error of the mean (SEM) is the standard BIOINFORMATION  open access 
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deviation of the sample mean estimate of a population mean. 
SEM is estimated by the sample estimate of the population 
standard deviation (sample deviation) divided by the square 
root of the sample size. Statistical analysis was carried out using 
one-way analysis of variance followed by Dunnet’s Multiple 
Comparison Test and p values implied significance (p<0.01) 
[31]. 
 
Molecular Modeling Studies: 
Molecular modeling studies have been carried out using GLIDE 
(Grid-based Ligand Docking with Energetics)  [30] software v5.5 
developed by Schrödinger running on Red Hat Enterprise 
Linux 5 (RHEL5) workstation. Maestro  v9.0 Graphical User 
Interface (GUI) workspace was used for all the steps involved in 
ligand preparation, protein preparation and Induced Fit 
Docking (IFD). 
 
Ligand Preparation: 
The ligands used in this study were prepared using LigPrep [35] 
module of v2.3 of Schrödinger Suite 2009. LigPrep  follows 
OPLS-AA  (Optimized Potential Liquid Simulations for All 
Atoms) force fields for energy minimization. In this study we 
used the crystal coordinates of the ligands Indomethacin 
(Figure 2a), OAP (4-(s)-[(1-oxo-7-phenylheptyl) amino]-5-[4-
(phenylmethyl)phenylthio] pentanoic acid) (Figure 2b) 
retrieved from their corresponding PDB complex structures and 
the crystal coordinates of TDTBPP obtained from the crystal 
data collected using Bruker’s Smart Apex II CCD Single-crystal 
X-ray diffractometer available in the department [18]. The 
crystal structure retrieved from PDB lack hydrogen atoms and 
hence hydrogen atoms were added to Indomethacin and OAP 
structures and energy minimized. 
 
 
Figure 2: (a) 3D crystal structure of Indomethacin obtained 
from 3H1X. (b) 3D crystal structure of OAP obtained from 
1KVO 
 
Protein Preparation: 
The X-ray crystal structures retrieved from PDB database as 
raw could not be suitable for molecular docking studies. A 
typical PDB structure consists only of heavy atoms, waters, 
cofactors, metal ions and can be of multimeric. These structures 
do not have the information about bond orders, topologies or 
formal atomic charges. The terminal amide groups may be 
misaligned because the X-ray structure analysis cannot 
distinguish between O and NH2. Ionization and tautomeric 
states are also unassigned. So, the raw PDB structure retrieved 
from PDB should be prepared in a suitable manner for docking. 
Protein Preparation Wizard of GLIDE software was used to 
process and prepare the protein. This Wizard allows one to 
properly prepare a protein for docking studies. This also 
follows the Optimized Potential for Liquid Simulations-All 
Atoms (OPLS-AA) force fields for energy minimization. 
Preparation of Daboia russelli’s venom sPLA2:  The X-ray crystal 
structure of D. russelli’s venom sPLA2 (PDB id: 3H1X) retrieved 
from  PDB is a  m onome ric  structure. It c onsist s of  120  a m ino 
acids with one inhibitor molecule Indomethacin, 243 water 
molecules and 3 sulphate ions. The protein was prepared by 
removing all the water molecules and sulphate ions present in 
the structure. Since the raw data do not contain any hydrogen 
in it, the implicit hydrogen atoms were added to the atoms to 
satisfy their appropriate valancies. Then the structure was 
optimized by assigning the bond orders, bond angles and 
topology. The formal atomic charges were fixed for the amino 
acid residues. The optimized structure was then energy 
minimized to remove the steric clashes between the atoms. The 
energy minimization was done till it reached a Root Mean 
Square Deviation (RMSD) cutoff of 0.18 Å and the resulting 
structure was used for docking.  
 
Preparation of Hnps PLA2: 
The X-ray crystal structure of Hnps PLA2 (PDB id: 1KVO) was 
retrieved from the PDB database. 1KVO is a hexameric 
structure with six identical chains. A monomeric unit consists of 
one OAP (co-crystallized inhibitor), 2 calcium metals (CA191 
and CA192) and 96 water molecules. Since all the 6 chains were 
identical, a single chain with OAP, calcium metal (CA191 
chelated to OAP and active site residues) and one water 
molecule (HOH1260, a significant metabolic water) were 
retained and used for further preparation steps. The remaining 
95 water molecules of the retained chain and the other five 
monomeric units (124 × 5 amino acid residues, 2 × 5 calcium 
metals and 96 × 5 water molecules) were removed. The implicit 
hydrogen atoms were added to the structure so as to satisfy 
their valancies. Then the bond orders, bond angles, topology 
and the formal atomic charges for the amino acid residues were 
assigned. The calcium metal in the structure was treated and 
ionized to Ca2+ ionic state. The structure was then energy 
minimized until it reached a RMSD of 0.18 Å and used for 
docking. 
 
Induced Fit Docking (IFD):  
 IFD of the prepared ligands with the prepared proteins was 
performed using Induced Fit Docking protocol of GLIDE v5.5 
from Schrödinger Suite 2009 [31]. It is based on GLIDE and 
Prime Refinement module. Prime accurately predicts the ligand 
binding modes and concomitant structural changes in the 
receptor. In IFD, both the ligand and the receptor are flexible 
which enables to dock the ligand at the receptor’s binding site 
to generate multiple poses of the receptor-ligand complex, each 
including unique structural conformations of the receptor to fit 
the ligand pose and ranks them by Glide score (G-score) to find 
the best structure of the docked complex. G-score takes into 
account a number of parameters like hydrogen bonds (H-bond), 
hydrophobic contacts (Lipo), van der-Waals (vdW), columbic 
(Coul), polar interactions in the binding site (Site), metal-
binding term (Metal) and penalty for buried polar group 
(BuryP) and freezing rotatable bonds (RotB) G-score = H bond 
+ Lipo + Metal + Site + 0.130 Coul + 0.065 vdW – BuryP – RotB. 
The prepared structures of 3H1X and 1KVO were used for BIOINFORMATION  open access 
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induced fit docking simulations. Initially a receptor grid, where 
the ligand has to be docked with the receptor was set by picking 
the centroid of the co-crystallized inhibitor (Indomethacin in 
3H1X and OAP in 1KVO) present at the active site. It creates a 
grid box and the size of the grid box was limited to 20 Å. The 
generation of different conformations of the docked complexes 
(poses) was set to a maximum of 20. Then TDTBPP was docked 
at the active site of 3H1X and 1KVO individually. The poses 
generated were ranked based on G-score. The pose that made 
the maximum hydrogen bond (H-bond) interactions from 
TDTBPP-3H1X and TDTBPP-1KVO docked complexes were 
considered for further analysis and the results are compared. 
 
Visualization and Analysis: 
The PyMol Molecular Graphics System [37] was used to analyze 
the hydrogen bond interactions and preparation of high 
resolution images. The hydrophobic interactions were obtained 
as Ligplot diagram by submitting the docked complexes to the 
online PDBsum server (http://www.ebi.ac.uk/pdbsum). 
 
 
Figure 3: Cartoon representation of native form of Daboia 
russelli’s venom sPLA2 (PDB id: 2PYC) showing the H1, H2, H3 
α-helices, β-wing, Ca2+ binding loop, anti-coagulant loop and 
the key residues Trp31, His48, Asp49 and Lys69. 
 
Results and Discussion: 
Acute anti-inflammatory Activity: 
TDTBPP at the dose of both 50 mg/kg and 70 mg/kg exhibited 
significant anti-inflammatory activity in carrageenan induced 
paw odema model (p<0.01) (Table 1, see supplementary 
material). No mortality of rats was observed and hence it is 
non-toxic in the administered dosages. It is well known that 
carrageenan induced paw edema model is commonly used as 
an experimental model for evaluating anti inflammatory 
activity of natural products [32] and is believed to be biphasic, 
of which the first phase is mediated by the release of histamines 
and 5 hydroxy tryptamin in the early stage followed by kinin 
release and then prostaglandin in the later stage. Prostaglandins 
and bradykinins were suggested to play important role in 
carrageenan induced edema [33, 34]. Both steroidal and non 
steroidal anti-inflammatory drugs can be tested by the 
carrageenan-induced paw inflammation test. The edema 
induced in the rat paw by the injection of 1% carrageenan is 
brought about by autocoids, histamine and 5-hydroxy 
tryptamine (5-HT) during the first one hour, after which kinins 
act, to increase the vascular permeability upto two and a half 
hours. The maximum inflammation is seen approximately three 
hours post the carrageenan injection, after which it begins to 
decline. Following that the prostaglandins act from two and a 
half hours to six hours, which results in the migration of 
leucocytes into the inflamed site [35, 36]. 
 
IFD of TDTBPP with 3H1X: 
3H1X  is a low molecular weight protein (13.6 kDa) and the 
structure of PLA2 consists of N-terminal helix, H1 (residues: 2-
12), a calcium binding loop (residues: 25-35), a second α-helix, 
H2 (residues: 40-55), a short two stranded antiparallel β-sheet/β 
wing (residues: 75-84) and a third α-helix, H3 (residues 90-108) 
[28]. The anti-coagulation region of the protein lies between the 
residues 54 and 77 and it is positively charged with the residues 
such as Lys69, Arg72, Arg74, Lys76 and Arg77 [37]. The 
opening and closure of Trp31 was observed in 
substrate/inhibitor bound and unbound form of the protein 
[38] (Figure 3). During the IFD of TDTBPP at the active site of 
3H1X, the Trp31 residue remains in open conformation, but the 
side chain of the residue found to be displaced to a distance of 
2.6 Å by 95.5°down through the C(γ) atom when compared 
with the IFD results of Indomethacin with 3H1X. The side chain 
of Lys69 was bent 71.2° down to a distance of 1.9Å through the 
C(δ) atom when compared to Indomethacin-3H1X complex, 
which favored the oxygen atom O(2) bonded to the central 
phosphorus atom of TDTBPP to make a H-bond interaction 
with the N(ε) atom at a distance of 2.83Å. The tert-butyl group 
of the phenyl ring was inserted in between His 48 and Asp 49 
and makes hydrophobic contact with them. In addition to that, 
all the three tert- b u t y l p h e n y l  r i n g  s y s t e m  o f  t h e  m o l e c u l e  
formed an array of hydrophobic interactions with the residues 
Phe5, Tyr22, Ser23, Tyr28, Gly30, Gly32, Tyr52, Gly53, Pro56, 
Cys61 and Pro68 lining the binding region (Figure 4a).  The 
Glide score of TDTBPP is −5.0 and Glide energy is −50.9 
Kcal/mol  (Table 2, see supplementary material). IFD of 
Indomethacin into the active site of 3H1X has not influenced 
any significant structural changes in the overall conformation of 
the protein backbone. The docked orientation of Indomethacin 
was similar to the orientation found in the PDB complex. Trp31 
residue was in open conformation. Indomethacin exhibited 
three H-bonds with the active site residues. The O(3) of the 
carbonyl group of Indomethacin formed H-bonds with the 
N(δ1) atom of His48 at a distance of 2.99 Å and O(δ1) atom of 
Asp49 residue at a distance of 2.48Å, respectively. The O(2) of 
the carbonyl group is involved in H-bond with the N(ε) atom of 
the Lys69 at a distance of 2.93Å (Figure 4b). The G-score of is 
−5.2 and Glide energy is −41.1 Kcal/mol. The overall binding of 
TDTBPP was in such a way that the O(2) atom of phosphate 
group maintains the interaction with Lys69 of the anti-
coagulant region as exhibited by Indomethacin. The G-score 
was also almost same and the Glide energy (directly related 
with the binding energy) was higher than Indomethacin, which 
indicated that TDTBPP has higher binding energy when 
compared to Indomethacin. The tert-butylphenyl ring makes BIOINFORMATION  open access 
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hydrophobic contact with His48 and Asp49. These residues 
form a dyad, and along with other determinants stabilize the 
transition state of the catalytic assembly of the sPLA2 [39]. The 
molecule was well positioned within the hydrophobic channel 
of the newly identified binding site, which is effective in 
blocking the exposure of the amino acid residues present in the 
anti-coagulant region and also the catalytic region to bind the 
substrate, thereby arresting the enzymatic activity of PLA2. 
 
 
Figure 4: (a) H-bond and Hydrophobic interactions exhibited by TDTBPP with 3H1X. The O(2) atom of central phosphate group 
formed an H-bond with Lys69 (represented as black dotted lines with corresponding bond distance) in the anti-coagulant loop of 
the protein and the other active site residues His48 and Asp49 surrounding the tert-butylphenyl ring (b) H-bonds exhibited by 
Indomethacin with the active site residues of 3H1X. 
 
 
Figure 5: (a) The co-ordinations formed by Ca2+ ion with the oxygen atom of TDTBPP and other active site residues of 1KVO are 
represented in black dotted lines with their corresponding bond distances (b) The co-ordinations formed by Ca2+ ion with OAP and 
the active site residues of 1KVO. 
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IFD of TDTBPP with Hnps PLA2: 
1KVO is also a low molecular weight protein (14 kDa protein) 
found in both inflammatory cells [40, 41]  and a variety of 
inflammatory exudates fluids in soluble form [42]. The 
chemistry and catalytic activity of this protein is as similar to 
3H1X, but with some modifications in the residues forming 
hydrophobic channel and their modulations during the 
substrate binding. The O(2) of the central phosphate group of 
TDTBPP was chelated to the calcium ion at a distance of 2.28Å 
(Figure 5a). This is similar to the distances exhibited by OAP 
with calcium ion and other reported complexes. The calcium 
ion in this complex was also has pentagonal bipyramidal 
geometry. As in the PDB complex Gly30, Gly32, His28 and 
Asp49 were also chelated to the calcium ion. The water 
molecule HOH1260 was chelated to the calcium ion and makes 
a H-bond interaction with the oxygen atom O(1) of the central 
phosphate group of TDTBPP). The carbonyl group oxygen atom 
of Asp42 displaced about 0.4 Å distance has an H-bond with the 
main chain N atom of His28, which was not found in the re-
docked pose of OAP-1KVO complex. This bond may hold the 
residues in the calcium binding loop of the protein to remain 
stable in the TDTBPP bound form. The angle between the 
calcium ion and the chelating oxygen atoms of water molecule 
and TDTBPP is 49.8°.  The angle between the chelating oxygen 
atoms of His28 and TDTBPP with the calcium ion is 134.1°. The 
corresponding angle exhibited by sn-3 phosphate group of 
other classical inhibitors of PLA2 was about 164°. This is 
significant in the effective binding of TDTBPP with single 
phosphate group at the center of three phenyl rings. The angle 
between the chelating oxygen atoms of Asp49 and O(2) of 
TDTBPP with calcium ion is about 92.9°. The oxygen atoms of 
Asp49, Gly30 and Gly32 involved in the chelation with calcium 
ion are found to be near equatorial as reported in the PDB 
complex. This is much similar to that of the re-docked pose of 
OAP with 1KVO. The phenyl rings with substituted tert-butyl 
groups are well positioned within the hydrophobic channel of 
the protein and have hydrophobic interactions with Tyr22, 
Ala18, Ile9, His6, Phe5, Phe24, Gly23, Val31, Leu2, Try52 and 
Cys44 lining in the hydrophobic channel within a distance of 
4Å. This is much similar to the hydrophobic contacts exhibited 
by OAP. The Glide score is −6.8 and the Glide energy is −47.0 
Kcal/mol. This is also comparable to that of the co-crystallized 
ligand (OAP). The OAP was re-docked nearby the active site 
and the orientation was such that, the C(11) atom was displaced 
to a distance of 1.9 Å away, the phenyl ring attached to the S(11) 
was twisted about 72.9° down and the O(21) atom was 
displaced by 1.6Å away. The calcium ion in this re-docked 
complex was in the characteristic pentagonal bipyramidal 
configuration as that of the PDB complex. The OAP was bound 
near the binding site and coordinated with the calcium ion at a 
distance of 2.28Å. The oxygen atoms of His28, Gly30, Gly32, 
and Asp49 (bifurcated) are also involved in chelation with 
calcium ion. In addition to the direct coordination with calcium, 
the carbonyl oxygen O(32) atom of amide group of OAP is also 
involved in a water (HOH1260) mediated interaction with Ca2+ 
ion, which was not found in the original PDB complex (Figure 
5b). This water molecule was found to be displaced about 1.2 Å 
towards the calcium ion which has made it to make chelation 
with the calcium ion and H-bond interaction with the O(32) 
atom of OAP. The angle between the calcium ion and 
coordinating oxygen atoms of OAP and water molecule is about 
68.8°. The angle between the calcium ion and the chelating 
oxygen atoms of His28 and OAP was 145.4°. The corresponding 
angle was found to be 177° in the PDB complex. The difference 
in this angle in the re-docked complex may be due to the 
inclusion of water molecule within the channel and the 
interactive force exerted by it made the oxygen atom of His28 to 
significantly move about 0.7 Å when compared to the PDB 
complex. The chelation exhibited by the O(21) was not found in 
the re-docked complex due to the significant displacement, and 
it only had an H-bond with the N atom of the His48 as that of 
the PDB complex. The coordinating oxygen atoms of the amide 
carbonyl group of OAP and Gly30, Gly32 and Asp49 were on a 
near equatorial plane. O(32) atom also had an H-bond 
interaction with the N atom of Gly32. The O(31) atom of the 
carbonyl group was also found to have H-bond interaction with 
the N(ε) atom of Lys69. The re-docked pose of OAP also 
maintained the array of hydrophobic contacts with Cys27, 
Tyr22, Ala18, Ile9, His6, Phe5, Phe24, Gly23, Val31, Leu2, Try52 
and Cys44 like that of the PDB complex. The Glide energy and 
G-score of the re-docked complex were −65.6 Kcal/mol and 
−8.2, respectively (Table 3, see supplementary material). 
 
Conclusion: 
Literature survey shows the anti-inflammatory property of 
various parts of V. negundo. Recent literature survey [43] 
indicates that V. negundo is an antidote for D. russelli bites. The 
molecular docking with 3H1X and 1KVO confirms that 
TDTBPP can bind both the calcium independent as well as 
calcium dependent forms of sPLA2s. Hence Tris (2, 4-di-tert-
butylphenyl) phosphate (TDTBPP) can be co-crystallized with 
the sPLA2 and the in vitro binding mode and energy with the 
protein could be revealed. It may be a good start to use novel 
class of compounds from natural sources in treating 
inflammatory disorders and snake bites. 
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Supplementary material: 
 
Table 1: Anti-inflammatory activity of Tris (2, 4-di-tert-butylphenyl) phosphate isolated from Vitex negundo L. on carrageen 
induced paw edema model  
Group(n=6)  Dose (mg/kg)  Paw edema volume in mL (Mean ± S.E) 
0 mins  1hr  2 hr  3 hr  6hr 
Control  01% CMC in Phosphate buffer  0.01±0.005  0.11±0.04 0.20±0.09  0.23±0.09 0.19±0.08 
Test Group 1  50  0.01±0.005  0.29±0.03 0.31±0.05  0.37±0.05 0.31±0.05* 
Test Group 2  70  0.01±0.005  0.27±0.02 0.29±0.04  0.34±0.04 0.29±0.04* 
standard 20  0.01±0.005  0.23±0.01  0.28±0.03  0.30±0.04  0.21±00.03 
*Significant at p<0.01, p-values calculated by comparing with control by ANNOVA followed by Dunnet test. 
 
Table 2: Hydrogen bond interactions of Indomethacin and TDTBPP with the amino acids at the active site of Daboia russelli’s sPLA2 
S. No  Compound  H-Bond Interactions  DH…A Distance (Å)  Glide Score  Glide Energy (Kcal/mol) 
1 Indomethacin  His  48  N−H…O−H* 
Asp 49 C=O… H−O * 
Lys 69 N−H…O−C* 
2.99 
2.48 
2.93 
−5.2  −41.1 
2 TDTBPP  Lys 69 N−H…O=P* 2.83  −5.0  −50.9 
− Ligand; DH − Donor; A − Acceptor  
 
Table 3: Hydrogen bond/Coordination bond interactions of OAP and TDTBPP with the amino acids and Calcium ion at the 
binding site of Hnps PLA2  
S. No  Compound  H-Bond/Coordination Interactions  Distance (Å)  Glide Score  Glide Energy (Kcal/mol) 
1  OAP  His 28 C=O...Ca2+ 
Gly 30 C=O...Ca2+ 
Gly 30 N−H...O=C* 
Gly 32 C=O...Ca2+ 
Gly32 N−H…O=C* 
His 48 N...H−N* 
Asp 49 C=O...Ca2+ 
Asp 49 C−O...Ca2+ 
Lys 69 N−H...O−C* 
Ca2+...O=C* 
HOH 1260 H−O...Ca2+ 
HOH 1260 O−H...O=C* 
2.32 
2.98 
3.21 
2.99 
3.10 
2.18 
2.50 
2.48 
2.92 
2.28 
2.42 
2.79 
−8.2  −65.6 
2 TDTBPP  His 28 C=O…Ca2+ 
His 28 N−H...O=C 
Gly30 C=O…Ca2+ 
Gly 32 C=O…Ca2+ 
Asp 49 C=O…Ca2+ 
Asp 49 C−O…Ca2+ 
Ca2+…O=P* 
HOH 1260 H−O...Ca2+ 
HOH 1260 O−H...O−P* 
2.99 
2.98 
2.40 
2.27 
2.51 
2.41 
2.28 
2.24 
2.79 
−6.8  −47.0 
* − Ligand 